MUFG Americas’s Enzo Biochem, Inc. ENZ Stock Holding History

MUFG Americas’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-430	Closed	-$4K	–	1018
2017 Q4	$4K	Sell	430 -262	-38%	-$2.5K	﹤0.01%	916
2017 Q3	$7K	Buy	+692	New	+$7.68K	﹤0.01%	911

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MUFG Americas's ENZ Position: Q1 2018 in Review

MUFG Americas sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 430 shares — an estimated $4K sold.

MUFG Americas first reported a position in ENZ in Q3 2017 and held it in 2 quarters. The position peaked at $7K in Q3 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

MUFG Americas reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
MUFG Americas sold 430 Enzo Biochem, Inc. shares in Q1 2018, an estimated $4K.
MUFG Americas first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 2 quarters.
MUFG Americas's Enzo Biochem, Inc. position peaked at $7K in Q3 2017.
107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on MUFG Americas's 13F filing for Q1 2018, filed 7 May 2018.